Imperial Ginseng Products Ltd.
IGPFF
$0.0605
$0.010621.24%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | 311.10K |
| Gross Profit | -- | -- | -- | -- | -311.10K |
| SG&A Expenses | 141.10K | 167.50K | 290.40K | 536.30K | 1.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 141.10K | 167.50K | 290.40K | 536.30K | 1.46M |
| Operating Income | -141.10K | -167.50K | -290.40K | -536.30K | -1.46M |
| Income Before Tax | 117.20K | 125.90K | 184.30K | 207.70K | 3.00M |
| Income Tax Expenses | -11.20K | -11.20K | -11.20K | 54.10K | 750.10K |
| Earnings from Continuing Operations | 0.13 | 0.14 | 0.20 | 0.15 | 2.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 128.40K | 137.10K | 195.50K | 153.60K | 2.25M |
| EBIT | -141.10K | -167.50K | -290.40K | -536.30K | -1.46M |
| EBITDA | -3.80K | -43.00K | -171.30K | -455.00K | -1.40M |
| EPS Basic | 0.02 | 0.02 | 0.03 | 0.02 | 0.29 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.07 |
| EPS Diluted | 0.01 | 0.02 | 0.02 | 0.02 | 0.29 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.07 |
| Average Basic Shares Outstanding | 30.61M | 30.61M | 30.61M | 30.61M | 30.61M |
| Average Diluted Shares Outstanding | 30.61M | 30.61M | 30.61M | 30.61M | 30.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 9,799.92% | 9,178.05% | 6,436.37% | 8,192.12% | -- |